News & Insights
Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.
Filters
Filters
Therapeutic Areas
In Vivo AI Platforms
Mental Illness
Neurodegenerative Disorders
Neurodevelopmental Disorders
Neuromuscular Disorders
Pain
Sleep & Seizure Disorders
Rare CNS Disorders
Traumatic Brain Injury
Specific Disorders
Apply Filters
Filters
PUBLICATION
Male and female Fmr1 knockout mice on C57 albino background exhibit spatial learning and memory impairments. Genes, Brain and Behavior
May 27, 2010
PUBLICATION
On the role of P2X(7) receptors in dopamine nerve cell degeneration in a rat model of Parkinson’s disease: studies with the P2X(7) receptor antagonist A-438079.
May 25, 2010
PUBLICATION
MitoPark mice mirror the slow progression of key Parkinson disease symptoms and the L-DOPA response. Genes, Brain and Behavior
March 20, 2010
PUBLICATION
Anxiolytic effects of lamotrigine and JZP-4 in the elevated plus maze and in the four plate conflict test.
October 25, 2009
PUBLICATION
Reward-seeking and discrimination deficits displayed by hypodopaminergic mice are prevented in mice lacking dopamine D4 receptors.
October 20, 2009
PUBLICATION
Acquisition of peak responding
August 28, 2009
PUBLICATION
Differential sensitivity to SSRI and tricyclic antidepressants in juvenile and adult mice of three strains.
July 26, 2009
PUBLICATION
Behavioural and pharmacological mechanisms of bupropion’s anti-smoking effects: recent preclinical and clinical insights.
July 25, 2009
PUBLICATION
The neuropharmacological substrates of nicotine reward: reinforcing versus reinforcement-enhancing effects of nicotine.
June 29, 2009